02109nas a2200349 4500000000100000008004100001260002000042653002100062653001300083653001600096653001800112100001700130700001800147700001300165700001600178700001300194700001200207700001500219700001500234700001700249700001500266700001600281700001800297700001600315700002000331245008000351856007200431300001200503490000600515520121300521022002501734 2022 d bAI Publications10aGeneral Medicine10aCovid-1910aHanseníase10aEpidemiologia1 aSilva JDALPD1 aOliveira AEAD1 aMacri PP1 aOliveira WM1 aSilva TM1 aDias HB1 aDantas MCB1 aSantos HTP1 aDamasceno SS1 aSerpa GSDM1 aJúnior GPX1 aGalvão EMLNF1 aAraujo VFSD1 aMaslinkiewicz A00aLeprosy in times of the COVID-19 pandemic: An integrative literature review uhttps://ijaers.com/uploads/issue_files/4IJAERS-10202210-Leprosy.pdf a025-0330 v93 a
Leprosy is a chronic infectious pathology mainly caused by the intracellular pathogen Mycobacterium leprae. This bacterium especially inhabits skin macrophages and Schwann cells of peripheral nerves, causing skin disease and/or neuritis. COVID-19 is a severe acute respiratory disease (SARS-CoV-2), it emerged recently, while the causative agent of leprosy lasts for more than 2,000 years. Thus, the studies were published in the years 2020, 2021 and 2022, being the equivalent of 14.29% in the year 2020, 71.42% in the year 2021 and about 14.29% in the year 2022, most of the works were from Brazil 85.71%, against 14.29% from Nepal. Regarding the results exposed, it is worth noting that, due to the decrease in the underreporting of endemic diseases, such as leprosy, due to COVID-19 infection, concerns have arisen about the diagnosis and treatment of the disease because of the reduction in notification and demand from users. during the pandemic due to social isolation. Among the main issues, we can highlight the increase in the difficulty of access to health and poverty due to the obstruction of non-essential services, which mainly affects those who already live in precarious conditions.
a2349-6495, 2456-1908